Regeneron Pharmaceuticals (REGN) Accounts Payable & History | Stock Alarm

Demo Sign up Log In

Regeneron Pharmaceuticals · Accounts Payable

REGN Accounts Payable

Latest reported$939.00Mperiod endingDec 31, 2025

REGN FY Accounts Payable ($0.00 → $939.00M)

Annual accounts payable

High-resolution chart · PNG

REGN accounts payable history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Regeneron Pharmaceuticals Accounts Payable — Annual fiscal periods (USD)
Period ending	Accounts Payable (USD)
Dec 31, 2025	939,000,000
Dec 31, 2024	789,500,000
Dec 31, 2023	606,600,000
Dec 31, 2022	589,200,000
Dec 31, 2021	564,000,000
Dec 31, 2020	475,500,000
Dec 31, 2019	418,100,000
Dec 31, 2018	218,200,000
Dec 31, 2017	178,200,000
Dec 31, 2016	134,984,000
Dec 31, 2015	140,962,000
Dec 31, 2014	99,508,000
Dec 31, 2013	61,936,000
Dec 31, 2012	38,934,000
Dec 31, 2011	27,736,000
Dec 31, 2010	15,589,000
Dec 31, 2009	18,638,000
Dec 31, 2008	6,268,000
Dec 31, 2007	8,128,000
Dec 31, 2006	4,349,000
Dec 31, 2005	4,203,000
Dec 31, 2004	4,407,000
Dec 31, 2003	18,933,000
Dec 31, 2002	30,309,000
Dec 31, 2001	14,830,000
Dec 31, 2000	9,446,000
Dec 31, 1999	6,600,000
Dec 31, 1998	5,600,000
Dec 31, 1997	4,700,000
Dec 31, 1996	4,400,000
Dec 31, 1995	6,300,000
Dec 31, 1994	5,000,000
Dec 31, 1993	10,300,000
Dec 31, 1992	2,500,000
Dec 31, 1991	1,600,000
Dec 31, 1990	0

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.